Camp4 Therapeutics Corp (CAMP) income statement
CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.10+0.10 (+2.50%)
Close on Nov 18, 2026Market cap $257.29MP/E –Yield 0.00%
Camp4 Therapeutics Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -1254.2%
- Net margin
- -2543.7%
- Return on equity, FY2025
- -145.1%
Financial strength
- Current ratio
- 4.70
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 451.4%
Valuation
- P/E ratio
- –
- Price to sales
- 61.03
- Price to book
- –
- Dividend yield
- 0.00%
See a number that looks wrong?